Protein Summary
- ENST00000398245
- ENSP00000381297
- ENSG00000138867
- ENST00000404664
- ENSP00000384121
- ENST00000407471
- ENSP00000386076
- ENST00000435822
- ENSP00000405985
- C22orf13
- LLN4
- LLN4
- C22orf13
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
histone modification site profile | 0.79 | ||
transcription factor binding site profile | 0.74 | ||
transcription factor perturbation | 0.74 | ||
kinase perturbation | 0.71 | ||
tissue sample | 0.64 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 5.62 (req: < 5)
Gene RIFs: 2 (req: <= 3)
Antibodies: 73 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 5.62 (req: >= 5)
Gene RIFs: 2 (req: > 3)
Antibodies: 73 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Term: 0
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0